Ingredient

Pirtobrutinib

Purtobrutinib is a targeted anticancer agent used for the treatment of malignant tumors.

See medicines used for Others & Special
All medicines
2
Single ingredient
2
Prescription medication
2

MFDS ingredient code M284756

What does it do?

Purtobrutinib is a targeted anticancer agent that selectively inhibits Bruton's tyrosine kinase (BTK). It is primarily used in the treatment of specific malignant tumors, such as hematologic cancers, and is aimed at interfering with the growth and survival of cancer cells.

Purtobrutinib obstructs the activity of the BTK enzyme within cancer cells, disrupting the signaling pathways of these cells. As a result, the proliferation and survival of cancer cells are inhibited, thereby delaying tumor growth.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike conventional BTK inhibitors, Purtobrutinib has high selectivity and durability, which reduces the potential for resistance and minimizes side effects. This is a distinguishing advantage over other BTK inhibitors.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

2 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.